Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Muzi

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapyJeffrey Tseng, Lisa K Dunnwald, Erin K Schubert, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human dataPeng Hsiao, Lucy Sasongko, Jeanne M Link, et al.
Molecular Imaging|August 19, 2003
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysisJoanne M Wells, David A Mankoff, Mark Muzi, et al.
IEEE Transactions on Radiation and Plasma Medical Sciences|November 23, 2020
Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scannerVarsha Viswanath, Austin R Pantel, Margaret E Daube-Witherspoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
The FDG lumped constant in normal human brainMichael M Graham, Mark Muzi, Alexander M Spence, et al.
Physics in Medicine and Biology|February 14, 2017
A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapyKristen A Wangerin, Mark Muzi, Lanell M Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibitionAlice Ban Ke, Sara Eyal, Francisco S Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastasesRobert K Doot, Mark Muzi, Lanell M Peterson, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapyJeffrey Tseng, Lisa K Dunnwald, Erin K Schubert, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human dataPeng Hsiao, Lucy Sasongko, Jeanne M Link, et al.
Molecular Imaging|August 19, 2003
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysisJoanne M Wells, David A Mankoff, Mark Muzi, et al.
IEEE Transactions on Radiation and Plasma Medical Sciences|November 23, 2020
Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scannerVarsha Viswanath, Austin R Pantel, Margaret E Daube-Witherspoon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
The FDG lumped constant in normal human brainMichael M Graham, Mark Muzi, Alexander M Spence, et al.
Physics in Medicine and Biology|February 14, 2017
A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapyKristen A Wangerin, Mark Muzi, Lanell M Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2013
Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibitionAlice Ban Ke, Sara Eyal, Francisco S Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyondDavid A Mankoff, Janet F Eary, Jeanne M Link, et al.
Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [<sup>18</sup>F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastasesRobert K Doot, Mark Muzi, Lanell M Peterson, et al.
Pageof 9